LOXL 2 Promotes the Epithelial–Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction]

OncoTargets and Therapy · Published 2026-07-01 · DOI 10.2147/ott.s636792

Free full text

Authors (6)

Jing Tian, He-xi Sun, Ying-chun Li, Li Jiang, Shan-ling Zhang, Quan Hao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tian, J., Sun, H., Li, Y., et al. (2026). LOXL 2 Promotes the Epithelial–Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction]. OncoTargets and Therapy. https://doi.org/10.2147/ott.s636792

Related articles

• Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer · OncoTargets and Therapy · 2026 · Same journal
• Advances in the Treatment of Breast Cancer at Different Stages of Pregnancy · OncoTargets and Therapy · 2026 · Same journal
• MST4 Regulates Epithelial–Mesenchymal Transition of Choriocarcinoma by Mediating TGF-β1 Expression [Retraction] · OncoTargets and Therapy · 2026 · Same journal
• Survival Outcomes and Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated First-Line mFOLFOXIRI Plus Bevacizumab: A Real-World Study in Vietnam · OncoTargets and Therapy · 2026 · Same journal
• Identification of an m7G-Related lncRNA Signature for Prognostic Prediction and Immune Landscape Characterization in Early Gastric Cancer · OncoTargets and Therapy · 2026 · Same journal
• Response to Osimertinib Observed in Meningeal-Metastatic NSCLC with EGFR A763V Mutation: A Case Report and Literature Review · OncoTargets and Therapy · 2026 · Same journal
• Downregulation of Long Noncoding RNA TUG1 Inhibits Proliferation and Induces Apoptosis Through the TUG1/miR-142/ZEB2 Axis in Bladder Cancer Cells [Retraction] · OncoTargets and Therapy · 2026 · Same journal
• The Role of Genomics in the Development and Treatment of Multiple Myeloma: Understanding the Challenges and Opportunities · OncoTargets and Therapy · 2026 · Same journal
• Bladder-Preserving Platforms for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer · OncoTargets and Therapy · 2026 · Same journal
• Integrated CT Radiomics and Circulating Tumor Cell Analysis in Predicting Lung Adenocarcinoma Invasion: A Dual-Center Study with Implications for Personalized Treatment · OncoTargets and Therapy · 2026 · Same journal